Egrifta

Generic: tesamorelin

11.6 MG — Solution

Growth Hormone Releasing Factor Analog

Also known as: tesamorelin Egrifta SV Subcutaneous Solution Reconstituted

Coverage by Insurer

Informational only — Coverage rules change frequently; verify tier placement and restrictions with your plan or pharmacy before acting.
Source: CMS QHP JSON  ·  Checked: 15 hours, 14 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
AmeriHealth Caritas Next Silver Off-Marketplace Low + No Referrals Tier 5 - Specialty PA
AmeriHealth Caritas Next Bronze Essential + No Referrals Tier 5 - Specialty PA
AmeriHealth Caritas Next Gold Signature + No Referrals Tier 5 - Specialty PA
AmeriHealth Caritas Next Silver Premier + No Referrals Tier 5 - Specialty PA
AmeriHealth Caritas Next Silver Signature + No Referrals Tier 5 - Specialty PA
AmeriHealth Caritas Next Silver Off-Marketplace High + No Referrals Tier 5 - Specialty PA
AmeriHealth Caritas Next Silver Essential + No Referrals Tier 5 - Specialty PA
AmeriHealth Caritas Next Bronze Signature + No Referrals Tier 5 - Specialty PA
AmeriHealth Caritas Next Bronze Premier + No Referrals Tier 5 - Specialty PA
AmeriHealth Caritas Next Gold Premier + No Referrals Tier 5 - Specialty PA
Source: CMS QHP JSON  ·  Formulary date: Jun 10, 2026  ·  Checked: 15 hours, 14 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
Troy Medicare for Dual-eligible Beneficiaries (HMO D-SNP) Tier 5 - Specialty PA
AmeriHealth Caritas VIP Care (HMO D-SNP) Tier 5 - Specialty PA
Troy Medicare (HMO) Tier 5 - Specialty PA
Something not right?